poisar

Stocks · News reference

Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026

Fiscal.ai

Orchestra BioMed Holdings, Inc. announced that it will present data regarding its Virtue SAB (Sirolimus AngioInfusion Balloon) system at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Orchestra BioMed Holdings, Inc. (OBIO)

    Filed: 2026-11-09 AccNo: 0001104659-26-124502 Size: 587 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits